Caudate or other regions of calf brains, fresh from a slaughterhouse, were frozen at -200 until assayed (up to 2 weeks). Tissue was homogenized with a Brinkmann Polytron PT-10 in 40 volumes of ice-cold 50 mM Tris-HCI buffer, pH 7.7 at 250. The homogenate was centrifuged at 50,000 X g for 10 min on a Sorvall RC-2B centrifuge. The supernatant fluid was discarded; the pellet was rehomogenized in 50 volumes of the same buffer and recentrifuged. The supernatant fluid was discarded, and the pellet was homogenized in 100 volumes of 50 mM Tris-HCI buffer, pH 7.5 at 250, with 10 uM pargyline and 0.1% (weight/volume) ascorbic acid. This final tissue resuspension was placed in a 370 bath for 5 min and returned to ice for use in the binding assay.
proterenol is virtually inactive. The relative potencies of phenothiazines as inhibitors of specific dopamine binding correlates with their clinical potencies and actions on the dopamine-sensitive adenylate cyclase. Effects on dopamine receptors determine actions of major psychotropic drugs (1) . Antagonism by neuroleptic "antischizophrenic" drugs of a dopamine-sensitive adenylate cyclase correlates with pharmacological potency, suggesting that the cyclase is associated with the dopamine receptor (2) (3) (4) (5) . We now report direct binding of dopamine to apparent postsynaptic receptor sites in membrane fractions of the corpus striatum of calf and rat.
METHODS
Caudate or other regions of calf brains, fresh from a slaughterhouse, were frozen at -200 until assayed (up to 2 weeks). Tissue was homogenized with a Brinkmann Polytron PT-10 in 40 volumes of ice-cold 50 mM Tris-HCI buffer, pH 7.7 at 250. The homogenate was centrifuged at 50,000 X g for 10 min on a Sorvall RC-2B centrifuge. The supernatant fluid was discarded; the pellet was rehomogenized in 50 volumes of the same buffer and recentrifuged. The supernatant fluid was discarded, and the pellet was homogenized in 100 volumes of 50 mM Tris-HCI buffer, pH 7.5 at 250, with 10 uM pargyline and 0.1% (weight/volume) ascorbic acid. This final tissue resuspension was placed in a 370 bath for 5 min and returned to ice for use in the binding assay.
The two preliminary washes with buffer remove endogenous dopamine, while preincubation at 370 ensures inactivation of tissue monoamine oxidase by pargyline before addition of radioactive dopamine.
Male Sprague-Dawley rats were decapitated and the corpus striatum was prepared as described for frozen calf tissue.
[3H]Dopamine (3,4-dihydroxyphenyl[ethyl-1- Other drugs with IC50s greater than 10,000 nM: (-)-amphetamine, (+)-amphetamine, cocaine, harmaline, a-methyldopa, a-methyl-p-tyrosine, diphenylhydantoin, ketamine, acetophenetidine, chlormezanone, lidocaine, ethosuximide, propranolol, methadone, naloxone, morphine, scopolamine, atropine, reserpine, y-aminobutyric acid, amatadine, methylphenidate, probenecid, octopamine, serotonin, glycine, carbachol, pyridoxine, isoniazid, tetracycline, aminosalicylic acid, nicotinamide, pyridoxal, anaphylthiourea, urea, hippuric acid, melatonin, alloxan, panthothenic acid, oxotremorine, physostigmine, benactyzine, meprobamate, and pentobarbital. Data (Fig. 2) (2) (3) (4) (5) . Geometrical and optical isomers of certain of these drugs differ dramatically in their apparent ability to block dopamine receptors in pharmacological screening tests in vivo (8) (9) (10) , and in their effects on the dopamine-sensitive adenylate cyclase (4, 11) and dopamine release from brain slices (12 (Fig. 4) .
Fluphenazine, which is active in considerably lower doses than chlorpromazine, is one of the most potent of the clinically used phenothiazines, while promethazine is a phenothiazine with little or no efficacy in treating schizophrenia (13) . In the calf corpus striatum, fluphenazine, chlorpromazine, and promethazine have IC50 values for inhibiting dopamine binding of 325 nM, 1500 nM, and 15,000 nM, respectively. Clozapine, a dibenzodiazepine with pharmacologic properties resembling the phenothiazines, is about 30% weaker than chlorpromazine in competing for calf dopamine sites. Imipramine, a tricyclic antidepressant closely related in structure to the phenothiazines but lacking antischizophrenic activity, requires concentrations of 25,000
Physiology: Burt et al. The data shown in the first two columns are based on experiments in which the standard assay conditions were modified by addition of the following ions: NaCl, 120 mM; KCl, 5 mM; CaCl2, 2 mM; MgCl2, 1 mM. In other experiments these ions were shown to have no effect on binding and drug effects. In the second column fresh rat corpus striatum was used. With the rat tissue, specific binding represented only about 21% of the total, whereas it was 47% of the total in the calf. The butyrophenones have pharmacological properties in animals and man which are essentially the same as those of the phenothiazines. The butyrophenones are, in general, more potent in vvo than the phenothiazines in eliciting apparent dopamine receptor blockade (14) . However, they are relatively weak inhibitors of the dopamine-sensitive adenylate cyclase, and their influences on this enzyme do not correlate with their pharmacological potency in vvo (3) (4) (5) .
Similarly Dopamine and apomorphine appear to have less affinity for the dopamine binding sites in striatal membranes of rat than calf. The ICs5 values for dopamine and apomorphine in rat striatal membranes are 380 and 180 nM, respectively, compared to 10 and 5 mM for dopamine and apomorphine, respectively, in the calf. Isoproterenol is essentially inactive in both the rat and calf. Whereas (+)-butaclamol and a-flupenthixol have similar potencies in both rat and calf, haloperidol is 5-fold less potent in the rat than calf and all the phenothiazines are between 5-and 10-fold more potent in the rat than calf.
Evidence Indicating that Dopamine Binding Sites Do Not Involve Presynaptic Membranes. To examine whether dopamine binds to presynaptic dopamine terminals, unilateral lesions of the nigrostriatal dopamine pathway were performed by administration of 6-hydroxydopamine into the substantia nigra. Three weeks after lesions that destroy 90% of dopamine nerve terminals in the corpus striatum, we de- 
